Isos Acquisition Corp. (NYSE:ISOS) announced this afternoon that its shareholders have approved its combination with bowling center operator Bowlero in a special meeting held yesterday.
The business combination was approved by a majority of Isos stockholders as approximately 90% of the votes cast at the meeting were in favor of the transaction.
Although Isos did not disclose redemption amounts, it traded below its trust value of $10 throughout its redemption deadline, December 10.
Nonetheless, the combined company’s stock and warrants are expected to begin trading on the NYSE Global Market under the symbols “BOWL” and “BOWL WS,” respectively, tomorrow, December 16.
Isos initially announced the $2.6 billion combination with Bowlero earlier this year on July 1. New York-based Bowlero is the world’s largest owner and operator of bowling centers with 321 in its portfolio and it also runs bowling media and digital gaming properties.
ADVISORS
- J.P. Morgan Securities LLC is serving as financial advisor to Bowlero.
- Paul, Weiss, Rifkind, Wharton & Garrison LLP is acting as legal advisor to Bowlero.
- Davis Polk is acting as legal advisor to Atairos, a significant current holder of Bowlero’s equity.
- Proskauer is acting as legal advisor to management. LionTree Advisors LLC is serving as financial advisor and placement agent to Isos.
- J.P. Morgan Securities LLC is acting as lead placement agent and capital markets advisor to Isos.
- Skadden, Arps, Slate, Meagher & Flom LLP is acting as legal advisor to J.P. Morgan Securities LLC and LionTree Advisors LLC in their capacities as placement agents.
- Hughes Hubbard & Reed LLP is acting as legal advisor to Isos
At the SPAC of Dawn (UPDATED) It was a slow start to the day after the Christmas holiday, especially because the SEC was “experiencing technical difficulties” this morning. That makes for a slow news day. Other than that, we hope everyone had a great holiday and is easing back into the work flow. Deals and...
Aimei Health Technology II Co., Ltd (NASDAQ:AHJKU) has filed for a $60 million SPAC ostensibly to pair up with a small cap biotech or medical device target, but its team’s experience both in SPACs and beyond suggest the vehicle will be open to a broad set of potential targets. It is the first SPAC to...
At the SPAC of Dawn The markets got to open one stocking early yesterday, but it was mostly coal as it showed durable goods orders had declined by more than twice as much as expected to -1.1% in November. It wasn’t all signs of naughtiness, however. Amid the numbers that came public one day earlier...
Copley Acquisition Corp has filed to raise a $150 million SPAC to hunt for a technology or lifestyle target in either the Asia Pacific or North America regions. The new S-1 also advances underwriter Clear Street in the league tables as it has backed two of the three latest SPACs to file in December, and...
Translational Development Acquisition Corp. (NASDAQ: TDACU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “TDACU”, Monday, December 23, 2024. The new SPAC intends to take a generalist approach in searching for a business combination, but intend to focus on industries that...